A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease

Clinical trial NCT03165071 · COMPLETED

Trial details

NCT number: NCT03165071
Sponsor: Idorsia Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Renal Impairment Healthy Subjects

Start date: 2017-06-03
Primary completion: 2017-10-27
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.